Global Over the past year, PharmaBoardroom has spoken to pharma executives the world over, collecting unique perspectives from all sides of the industry. Here are the ten most-read interviews of 2022 that range from conversations with one of Korea’s top CDMOs to the American generics association and the Italian regulatory agency,…
Middle East & Africa Mediclinic Middle East’s CEO David Hadley explains the UAE’s response to the pandemic and how Mediclinic was involved. He also discusses the oversupply of hospitals and other healthcare trends in the region. The pandemic encouraged people to focus more on their health in one way or another. This creates the…
Long Read Accounting for less than two percent of the global pharmaceutical market, the Middle East has long been somewhat overlooked by many drug makers, most of whom seemed more intent on chasing demand in the decidedly more populous Asian market space. But, with an estimated annual growth rate of 10 percent,…
UAE Mediclinic Middle East, the largest private healthcare group in the UAE, is betting on the continuum of care to continue thriving in a highly competitive market. CEO David Hadley explains the company’s presence in the country, with seven hospitals and 21 clinics, and provides insights into the UAE healthcare industry’s…
See our Cookie Privacy Policy Here
